BioLine Rx Ltd (BLRX)
0.7039
+0.02
(+3.51%)
USD |
NASDAQ |
May 06, 16:00
0.7172
+0.01
(+1.89%)
After-Hours: 20:00
BioLine Rx Cash and Short Term Investments (Quarterly): 42.99M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 42.99M |
| September 30, 2023 | 25.97M |
| June 30, 2023 | 32.82M |
| March 31, 2023 | 43.29M |
| December 31, 2022 | 51.08M |
| September 30, 2022 | 57.26M |
| June 30, 2022 | 43.15M |
| March 31, 2022 | 50.59M |
| December 31, 2021 | 57.14M |
| September 30, 2021 | 62.20M |
| June 30, 2021 | 65.57M |
| March 31, 2021 | 58.08M |
| December 31, 2020 | 22.59M |
| September 30, 2020 | 20.83M |
| June 30, 2020 | 27.30M |
| March 31, 2020 | 21.18M |
| December 31, 2019 | 27.49M |
| September 30, 2019 | 30.14M |
| June 30, 2019 | 35.23M |
| March 31, 2019 | 40.61M |
| December 31, 2018 | 30.15M |
| September 30, 2018 | 35.00M |
| June 30, 2018 | 41.13M |
| March 31, 2018 | 44.20M |
| December 31, 2017 | 49.48M |
| Date | Value |
|---|---|
| September 30, 2017 | 55.01M |
| June 30, 2017 | 52.56M |
| March 31, 2017 | 30.37M |
| December 31, 2016 | 35.62M |
| September 30, 2016 | 38.91M |
| June 30, 2016 | 41.82M |
| March 31, 2016 | 45.01M |
| December 31, 2015 | 47.66M |
| September 30, 2015 | 50.71M |
| June 30, 2015 | 54.79M |
| March 31, 2015 | 57.49M |
| December 31, 2014 | 34.68M |
| September 30, 2014 | 29.66M |
| June 30, 2014 | 33.20M |
| March 31, 2014 | 37.33M |
| December 31, 2013 | 18.22M |
| September 30, 2013 | 20.08M |
| June 30, 2013 | 22.88M |
| March 31, 2013 | 28.04M |
| December 31, 2012 | 21.36M |
| September 30, 2012 | 13.43M |
| June 30, 2012 | 30.64M |
| March 31, 2012 | 25.24M |
| December 31, 2011 | 25.97M |
| September 30, 2011 | 30.03M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
20.83M
Minimum
Sep 2020
65.57M
Maximum
Jun 2021
40.78M
Average
42.99M
Median
Dec 2023
Cash and Short Term Investments (Quarterly) Benchmarks
| Compugen Ltd | 50.68M |
| Pluri Inc | 30.62M |
| XTL Biopharmaceuticals Ltd | 2.006M |
| Can Fite Biofarma Ltd | 8.922M |
| BiomX Inc | 14.91M |